PhuturdexDrug Pipeline Intelligence

Phuturdex › Diseases › Open-angle glaucoma

Drugs in development · updated 30 October 2026

Open-angle glaucoma: drugs in development

As of 30 October 2026 there are 11 active clinical trials (recruiting or ongoing, phases I–III) on 12 drugs for open-angle glaucoma. 9 are experimental, that is not yet approved in the United States.

11Active trials
9Experimental drugs
7Experimental, in phase III

Summary updated every week · data as of 30 October 2026. In Phuturdex you get the full detail of every drug and an email when an alert is published on the ones you follow.

Sign in free →

Experimental drugs

Not yet approved by the US FDA for any indication.

DrugMost advanced phaseActive trialsReference trial
NicotinamideNicotinomideIII2NCT05405868
CiticolineIII1NCT05710198
PyruvateII–III1NCT05695027
TFC-003III1NCT07662759
TFC-003-R1III1NCT07662759
TFC-003-R2III1NCT07662759
TFC-003-R3III1NCT07662759
EYED-002I–II1NCT07619482
REGN22530I–II1NCT07675824

Sorted by most advanced phase and number of active trials.

Approved drugs in new trials

Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.

DrugMost advanced phaseActive trialsReference trial
TimololIstalol®, Betimol®III2NCT07495852
COSOPTIII1NCT07617532
LatanoprostIyuzeh®, Xelpros®III1NCT06666855

Sorted by most advanced phase and number of active trials.

All 12 drugs, with the details

In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.

Open in Phuturdex →

Broader categories

Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: Wikidata; NLM MeSH term: D005902 “Glaucoma, Open-Angle”.

ItalianoFrançaisDeutsch